MARKET

XAIR

XAIR

Beyond Air Inc
NASDAQ
1.729
-0.121
-6.56%
Opening 14:19 11/19 EST
OPEN
1.810
PREV CLOSE
1.850
HIGH
1.840
LOW
1.660
VOLUME
28.92K
TURNOVER
--
52 WEEK HIGH
53.20
52 WEEK LOW
1.660
MARKET CAP
2.88M
P/E (TTM)
-0.0365
1D
5D
1M
3M
1Y
5Y
1D
Insider Traders Lose US$173k As Beyond Air Drops
Simply Wall St · 10h ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
Weekly Report: what happened at XAIR last week (1109-1113)?
Weekly Report · 3d ago
Beyond Air Earnings Call Highlights Growth and FDA Milestones
TipRanks · 4d ago
Beyond Air Reports Record Quarterly Revenue, Narrows Net Loss
TipRanks · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/12 12:05
Why Tetra Tech Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 11/12 09:56
Beyond Air Q3 Loss Narrows On Sales Rise; Backs Sales Outlook As Next-Gen LungFit PH Awaits FDA Nod
NASDAQ · 11/12 06:34
More
About XAIR
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Webull offers Beyond Air Inc stock information, including NASDAQ: XAIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XAIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XAIR stock methods without spending real money on the virtual paper trading platform.